Abdominal Tuberculosis Mimicking Cancer Clinically and on Fluorodeoxyglucose (FDG)-Positron Emission Tomography (PET) Imaging: A Two-Case Series.
Journal
The American journal of case reports
ISSN: 1941-5923
Titre abrégé: Am J Case Rep
Pays: United States
ID NLM: 101489566
Informations de publication
Date de publication:
05 Feb 2020
05 Feb 2020
Historique:
entrez:
6
2
2020
pubmed:
6
2
2020
medline:
9
9
2020
Statut:
epublish
Résumé
BACKGROUND Miliary tuberculosis (MT) is the disseminated form of tuberculosis (TB) and it is a potentially fatal condition. Diagnosis is often delayed because symptoms are typically nonspecific or absent, and misdiagnosis in favor of other diseases is common. We report 2 cases of disseminated TB that were diagnosed during or after surgeries performed for other suspected diseases. CASE REPORT Imaging findings are not specific and cannot be relied upon to raise suspicion of MT. In the first case, besides other imaging techniques, we also performed a positron emission tomography-computed tomography (PET-CT) on the patient and the resulting, thick, fluorodeoxyglucose (FDG)-avid ring surrounding the liver first led to concern for peritoneal carcinomatosis. TB peritonitis was only identified on laparoscopy and biopsy. In the second case, CT and magnetic resonance imaging (MRI) findings of a solitary liver mass with an irregular enhancing rim and progressive enhancement led to a radiographic diagnosis of likely intrahepatic cholangiocarcinoma, The subsequent finding that the lesion was intensely FDG-avid without other foci of FDG uptake led to the decision to proceed with resection without a prior biopsy. CONCLUSIONS We have presented 2 patients with TB in whom clinical and imaging findings, and in particular, FDG-PET imaging, led to an erroneous clinical diagnosis of malignancy. An awareness that TB remains very much an active clinical problem in North America and that there are other reasons for FDG uptake on PET imaging besides cancer, is necessary in order to avoid unnecessary and potentially deleterious interventions in patients with TB.
Identifiants
pubmed: 32019906
pii: 918901
doi: 10.12659/AJCR.918901
pmc: PMC7020736
doi:
Substances chimiques
Fluorodeoxyglucose F18
0Z5B2CJX4D
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e918901Références
Ann Gastroenterol. 2014;27(3):207-211
pubmed: 24976240
Medicine (Baltimore). 1972 Mar;51(2):139-55
pubmed: 5013636
Mayo Clin Proc. 2011 Apr;86(4):348-61
pubmed: 21454737
World J Gastroenterol. 2010 Sep 7;16(33):4237-42
pubmed: 20806445
BMC Gastroenterol. 2017 Nov 28;17(1):126
pubmed: 29179696
Indian J Med Res. 2012 May;135(5):703-30
pubmed: 22771605
BMJ Case Rep. 2018 Jun 6;2018:
pubmed: 29880621
Medicine (Baltimore). 2017 Jan;96(2):e5867
pubmed: 28079823
Q J Med. 1984 Autumn;53(212):465-77
pubmed: 6515002
Microbiol Spectr. 2017 Mar;5(2):
pubmed: 28281441
Clin Infect Dis. 2016 Dec 16;64(5):635-644
pubmed: 27986665
Indian J Med Res. 2005 Apr;121(4):550-67
pubmed: 15817963
AJR Am J Roentgenol. 2016 Oct;207(4):694-704
pubmed: 27341483
BMC Infect Dis. 2015 May 06;15:209
pubmed: 25943103